Shopping Cart 0
Cart Subtotal
USD 0

Acobiom - Product Pipeline Analysis, 2018 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 750

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 1500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 2250
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Acobiom is a biotechnology company that specializes in biomarker discovery and development of innovative diagnostics. The company undertakes the discovery of RNA and DNA biomarkers, which finds application in the areas of disease detection and classification, patient stratification, companion diagnosis and disease prognosis. It develops diagnostics centered on personalized medicine and precision medicine applications. Acobiom also provides services such as sequencing, next generation sequencing (NGS), bioinformatics, biostatistics, real time PCR, and others. The company offers technology platforms such as qRT-PCR, gene expression and bioinformatics. The company provides products in the areas of personalized medicines, medical products, leukemia and gemcitest, among others. Acobiom is headquartered in Montpellier, France.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Acobiom

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Acobiom Company Overview 5

Acobiom Company Snapshot 5

Acobiom Pipeline Products and Ongoing Clinical Trials Overview 5

Acobiom - Pipeline Analysis Overview 8

Acobiom - Key Facts 8

Acobiom - Major Products and Services 9

Acobiom Pipeline Products by Development Stage 10

Acobiom Ongoing Clinical Trials by Trial Status 14

Acobiom Pipeline Products Overview 15

Biomarker Test - Hantavirus 15

Biomarker Test - Hantavirus Product Overview 15

Companion Diagnostic Assay - Masitinib 16

Companion Diagnostic Assay - Masitinib Product Overview 16

Companion Diagnostic Assay - Prostate Cancer 17

Companion Diagnostic Assay - Prostate Cancer Product Overview 17

Companion Diagnostic Test - Alzheimer's Disease 18

Companion Diagnostic Test - Alzheimer's Disease Product Overview 18

Companion Diagnostic Test - Breast Cancer 19

Companion Diagnostic Test - Breast Cancer Product Overview 19

Companion Diagnostic Test - Lung Cancer 20

Companion Diagnostic Test - Lung Cancer Product Overview 20

Companion Diagnostic Test - Triple Negative Breast Cancer 21

Companion Diagnostic Test - Triple Negative Breast Cancer Product Overview 21

Diagnostic Assay - Chronic Myelomonocytic Leukemia 22

Diagnostic Assay - Chronic Myelomonocytic Leukemia Product Overview 22

Diagnostic Test - Dengue 23

Diagnostic Test - Dengue Product Overview 23

Diagnostic Test - Leishmania 24

Diagnostic Test - Leishmania Product Overview 24

Diagnostic/Prognostic Assay - Alzheimer's Disease 25

Diagnostic/Prognostic Assay - Alzheimer's Disease Product Overview 25

Diagnostic/Prognostic Assay - Breast Cancer 26

Diagnostic/Prognostic Assay - Breast Cancer Product Overview 26

Diagnostic/Prognostic Assay - Lung Cancer 27

Diagnostic/Prognostic Assay - Lung Cancer Product Overview 27

Diagnostic/Prognostic Assay - Pancreatic Cancer 28

Diagnostic/Prognostic Assay - Pancreatic Cancer Product Overview 28

GemciTest 29

GemciTest Product Overview 29

GemciTest Clinical Trial 30

Acobiom - Key Competitors 31

Acobiom - Key Employees 32

Acobiom - Locations And Subsidiaries 33

Head Office 33

Recent Developments 34

Acobiom, Recent Developments 34

Nov 03, 2012: Skuldtech And AB Science Announce Identification Of New Predictive Markers For Pancreatic Cancer Survival Associated With Masitinib Treatment 34

Appendix 35

Methodology 35

About GlobalData 38

Contact Us 38

Disclaimer 38


List Of Figure

List of Figures

Acobiom Pipeline Products by Equipment Type 6

Acobiom Pipeline Products by Development Stage 10

Acobiom Ongoing Clinical Trials by Trial Status 14


List Of Table

List of Tables

Acobiom Pipeline Products and Ongoing Clinical Trials Overview 5

Acobiom Pipeline Products by Equipment Type 6

Acobiom Pipeline Products by Indication 7

Acobiom Ongoing Clinical Trials by Trial Status 7

Acobiom, Key Facts 8

Acobiom, Major Products and Services 9

Acobiom Number of Pipeline Products by Development Stage 10

Acobiom Pipeline Products Summary by Development Stage 11

Acobiom Ongoing Clinical Trials by Trial Status 14

Acobiom Ongoing Clinical Trials Summary 14

Biomarker Test - Hantavirus - Product Status 15

Biomarker Test - Hantavirus - Product Description 15

Companion Diagnostic Assay - Masitinib - Product Status 16

Companion Diagnostic Assay - Masitinib - Product Description 16

Companion Diagnostic Assay - Prostate Cancer - Product Status 17

Companion Diagnostic Assay - Prostate Cancer - Product Description 17

Companion Diagnostic Test - Alzheimer's Disease - Product Status 18

Companion Diagnostic Test - Alzheimer's Disease - Product Description 18

Companion Diagnostic Test - Breast Cancer - Product Status 19

Companion Diagnostic Test - Breast Cancer - Product Description 19

Companion Diagnostic Test - Lung Cancer - Product Status 20

Companion Diagnostic Test - Lung Cancer - Product Description 20

Companion Diagnostic Test - Triple Negative Breast Cancer - Product Status 21

Companion Diagnostic Test - Triple Negative Breast Cancer - Product Description 21

Diagnostic Assay - Chronic Myelomonocytic Leukemia - Product Status 22

Diagnostic Assay - Chronic Myelomonocytic Leukemia - Product Description 22

Diagnostic Test - Dengue - Product Status 23

Diagnostic Test - Dengue - Product Description 23

Diagnostic Test - Leishmania - Product Status 24

Diagnostic Test - Leishmania - Product Description 24

Diagnostic/Prognostic Assay - Alzheimer's Disease - Product Status 25

Diagnostic/Prognostic Assay - Alzheimer's Disease - Product Description 25

Diagnostic/Prognostic Assay - Breast Cancer - Product Status 26

Diagnostic/Prognostic Assay - Breast Cancer - Product Description 26

Diagnostic/Prognostic Assay - Lung Cancer - Product Status 27

Diagnostic/Prognostic Assay - Lung Cancer - Product Description 27

Diagnostic/Prognostic Assay - Pancreatic Cancer - Product Status 28

Diagnostic/Prognostic Assay - Pancreatic Cancer - Product Description 28

GemciTest - Product Status 29

GemciTest - Product Description 29

GemciTest - Clinical Evaluation of GemciTest in the Treatment of Pancreatic Cancer Patients 30

Acobiom, Key Employees 32

Glossary 37

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Acobiom, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Applied Biosystems France SA

GenoSplice technology SARL

Firalis SAS

BioSystems International